We provide you with 20 years of free, institutional-grade data for MGNX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MGNX. Explore the full financial landscape of MGNX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-14 | 1125345 | MGNX | 10-Q | Url |
| 2025-05-13 | 1125345 | MGNX | 10-Q | Url |
| 2025-03-20 | 1125345 | MGNX | 10-K | Url |
| 2024-11-05 | 1125345 | MGNX | 10-Q | Url |
| 2024-08-06 | 1125345 | MGNX | 10-Q | Url |
| 2024-05-09 | 1125345 | MGNX | 10-Q | Url |
| 2024-03-07 | 1125345 | MGNX | 10-K | Url |
| 2023-11-06 | 1125345 | MGNX | 10-Q | Url |
| 2023-08-09 | 1125345 | MGNX | 10-Q | Url |
| 2023-05-09 | 1125345 | MGNX | 10-Q | Url |
| 2023-03-15 | 1125345 | MGNX | 10-K | Url |
| 2022-11-03 | 1125345 | MGNX | 10-Q | Url |
| 2022-08-08 | 1125345 | MGNX | 10-Q | Url |
| 2022-05-03 | 1125345 | MGNX | 10-Q | Url |
| 2022-02-24 | 1125345 | MGNX | 10-K | Url |
| 2021-11-02 | 1125345 | MGNX | 10-Q | Url |
| 2021-07-29 | 1125345 | MGNX | 10-Q | Url |
| 2021-04-29 | 1125345 | MGNX | 10-Q | Url |
| 2021-02-25 | 1125345 | MGNX | 10-K | Url |
| 2020-11-04 | 1125345 | MGNX | 10-Q | Url |
| 2020-07-31 | 1125345 | MGNX | 10-Q | Url |
| 2020-05-05 | 1125345 | MGNX | 10-Q | Url |
| 2020-02-25 | 1125345 | MGNX | 10-K | Url |
| 2019-11-06 | 1125345 | MGNX | 10-Q | Url |
| 2019-07-31 | 1125345 | MGNX | 10-Q | Url |
| 2019-05-01 | 1125345 | MGNX | 10-Q | Url |
| 2019-02-26 | 1125345 | MGNX | 10-K | Url |
| 2018-11-07 | 1125345 | MGNX | 10-Q | Url |
| 2018-08-07 | 1125345 | MGNX | 10-Q | Url |
| 2018-05-07 | 1125345 | MGNX | 10-Q | Url |
| 2018-02-27 | 1125345 | MGNX | 10-K | Url |
| 2017-11-08 | 1125345 | MGNX | 10-Q | Url |
| 2017-08-02 | 1125345 | MGNX | 10-Q | Url |
| 2017-05-03 | 1125345 | MGNX | 10-Q | Url |
| 2017-02-28 | 1125345 | MGNX | 10-K | Url |
| 2016-11-02 | 1125345 | MGNX | 10-Q | Url |
| 2016-08-03 | 1125345 | MGNX | 10-Q | Url |
| 2016-05-04 | 1125345 | MGNX | 10-Q | Url |
| 2016-02-29 | 1125345 | MGNX | 10-K | Url |
| 2015-11-04 | 1125345 | MGNX | 10-Q | Url |
| 2015-08-05 | 1125345 | MGNX | 10-Q | Url |
| 2015-05-06 | 1125345 | MGNX | 10-Q | Url |
| 2015-03-03 | 1125345 | MGNX | 10-K | Url |
| 2014-11-12 | 1125345 | MGNX | 10-Q | Url |
| 2014-08-05 | 1125345 | MGNX | 10-Q | Url |
| 2014-05-06 | 1125345 | MGNX | 10-Q | Url |
| 2014-03-20 | 1125345 | MGNX | 10-K | Url |
| 2014-01-30 | 1125345 | MGNX | S-1 | Url |
| 2013-11-12 | 1125345 | MGNX | 10-Q | Url |
| 2013-09-04 | 1125345 | MGNX | S-1 | Url |
MacroGenics, Inc(NASDAQ:MGNX) 
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. The company's approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in com...
Website: http://www.macrogenics.com
Founded: 2000
Full Time Employees: 384
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MGNX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.